CuraCell TX AB
559280-8546ActiveEuropean biotech developing personalized T-cell therapies for solid cancer tumors.
Biotechnology Companycuracell.se
Yleiskatsaus
- 5
- Työntekijät
- 45t SEK
- Liikevaihto
- 2020
- Perustettu
Avainpäättäjät
Håkan Hallberg
CFO
Lucas Arruda
Chief Scientific Officer
Thomas Schlegel
General Counsel
Jonas Båtelson
CEO
+3 lisää yhteystietoja Funnelfeedrissä
Kuvaus
CuraCell is a European biotech company focused on developing innovative T-cell therapies for the treatment of solid cancer tumors. The company utilizes its proprietary platform, CytoPLY, designed to significantly expand and activate the patient's own tumor-reactive T-cells. Their primary therapeutic...
ZELLUNA ASA